Dan Azagury is a surgeon and health technology innovator with an international background. He is the Director for Education for the fellowship program at the Stanford's Byers Center for Biodesign. He teaches multidisciplinary teams a process to identify important healthcare needs and develop novel health technologies to address them. He also teaches in multiple international medical innovation programs and co-directs the Japan Biodesign partnership program. He is an Associate Professor of Surgery at Stanford University School of Medicine and serves as Medical Director for the Stanford Bariatric and Metabolic Interdisciplinary clinic as well as fellowship director for Minimally Invasive and Bariatric surgery. Dr. Azagury graduated from medical school in Switzerland, completed surgical residency at the Geneva University Hospital, and undertook research and clinical fellowships at Brigham and Women's Hospital and Harvard Medical School. He then completed the Biodesign Innovation Fellowship at Stanford and co-founded Ciel Medical along with his Biodesign teammate Kate Garrett. Together they developed novel solutions for intubated patients in the ICU. Ciel Medical was acquired by Vyaire Medical in 2017. Dr. Azagury's research focuses on multidisciplinary approaches to improving bariatric surgery outcomes as well as medical device innovation. He holds three patents and has published over 75 scientific articles and book chapters.

Lyn Denend is Director for Academic Programs at Stanford's Byers Center for Biodesign and a Lecturer in the Stanford School of Medicine. In her Biodesign role, she leads curriculum development and program execution across Stanford Biodesign’s portfolio of educational offerings. She teaches numerous courses, including the graduate-level Biodesign Innovation class, Global Biodesign: Health Technology in an International Context, and the undergraduate Needs Finding in Healthcare program. Lyn spearheaded Stanford Biodesign’s efforts to codify its core innovation process, is the principal author of the textbook Biodesign: The Process of Innovating Medical Technologies (1st and 2nd editions), and led the development of more than 350 open-source videos available at ebiodesign.org. She also helps disseminate best practices in health technology innovation education as an organizing member of the Biomedical Engineering-Innovation, Design, and Entrepreneurship Alliance (BME-IDEA) in the United States and Asia Pacific. Prior to Stanford Biodesign, she created multimedia teaching materials at the Stanford Graduate School of Business, where she authored more than 100 case studies. Lyn was a Senior Manager with Ernst & Young’s management consulting practice. She has an MBA from Duke University’s Fuqua School of Business and a BA in Communications from the University of California at Santa Barbara.

Paul Yock is the Founder and Director of the Byers Center for Biodesign at Stanford University, a pioneering innovation training program dedicated to the design and development of medical technologies. He is also the Martha Meier Weiland Professor of Medicine and Mechanical Engineering and Founding Co-Chair of Stanford’s Department of Bioengineering. Paul is a cardiologist who received his M.D. from Harvard Medical School.

He is internationally known for his work in inventing, developing, and testing new devices, including the Rapid Exchange™ balloon angioplasty system, which is now the primary system in use worldwide, and Cardiovascular Imaging Systems, which was acquired by Boston Scientific in 1994. He has also co-founded several other medical technology companies.

In his academic career, Paul has authored over 300 peer-reviewed publications, chapters and editorials, textbooks, and over 45 U.S. patents. Current research interests focus on development and testing of catheter-based delivery systems for cardiac cell transplantation and new catheter and molecular imaging techniques for cardiology.